Updated:
Lumeris Group Holdings Corp
Dr. David Carmouche leads Lumeris, which manages $90B in medical spend through Tom™, its AI platform for value-based primary care.
Lumeris Group Holdings Corp
Lumeris is a physician-first healthcare transformation company dedicated to improving primary care through our AI-powered Primary Care as a Service platform.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Maryland Heights
Corporate office
Maryland Heights, MO, United States
Principals
David Carmouche
Executive Vice President
Sector focus
Frequently asked questions
How does Lumeris generate revenue, and does it invest capital directly?
Lumeris generates revenue through operational partnerships where it embeds its Tom™ platform into health systems and physician groups. It does not operate as a traditional investment firm or deploy a fund. Instead, it takes on clinical and financial risk alongside its partners, earning returns through the value-based care savings it helps generate. The firm has not publicly disclosed a pool of invested assets or a private capital vehicle.
What is Tom™ and how does it differentiate Lumeris from other healthcare AI platforms?
Tom™ is an AI-powered platform that serves as a core operating system for primary care delivery. It coordinates patient outreach, risk stratification, and care navigation between visits, functioning as an active member of the care team rather than a passive analytics tool. In May 2026, MedTech Breakthrough named it Best Care Orchestration Platform, indicating a focus on workflow integration that distinguishes it from point-solution AI tools.
Who runs investment and strategic decisions at Lumeris Group Holdings?
The firm’s public leadership presence is represented by Dr. David Carmouche, Executive Vice President. The firm has not publicly disclosed its full C-suite, board composition, or a centralized investment committee. Strategic decisions appear to flow through a physician-led operational leadership structure rather than a traditional principal investment office.
Does Lumeris participate in fund commitments or direct investments in healthcare companies?
There is no public evidence that Lumeris operates as an institutional allocator making fund commitments or direct minority investments. Its capital deployment is operational, tied to the resources required to embed its platform and assume risk in partner health systems. The firm has not disclosed a portfolio of equity stakes or LP interests.
What is Lumeris's relationship with the Collaborative for Healthy Rural America (CHRA)?
Lumeris is a participant in the Collaborative for Healthy Rural America. In May 2026, Lumeris announced that Instacart had joined CHRA to expand access to nutrition and essential goods, indicating that Lumeris uses the collaborative to coordinate partnerships that address social determinants of health for rural populations. The firm’s role in CHRA appears to be operational and convening rather than purely financial.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: